文献速递神经肌肉病

女性激素暴露与肌萎缩侧索硬化风险的病例对照研究:Euro-MOTOR

A case-control study of hormonal exposures as etiologic factors for ALS in women: Euro-MOTOR.
PubMed 文献 · Neurology · 2017-08-23

该研究在爱尔兰、意大利和荷兰纳入653例女性ALS患者和1217例匹配对照,用问卷记录激素暴露,经多因素调整的逻辑回归分析。口服避孕药使用与ALS风险降低相关(OR 0.65,95%CI 0.51-0.84),且呈剂量反应;激素替代治疗仅在荷兰显示风险降低(OR 0.57,95%CI 0.37-0.85)。结论认为外源性雌激素和孕激素与女性ALS风险降低相关,但需进一步研究。

要点

  • 口服避孕药使用与女性ALS风险降低相关(OR 0.65,95%CI 0.51-0.84)。
  • 激素替代治疗仅在荷兰显示ALS风险降低(OR 0.57,95%CI 0.37-0.85)。
  • 激素因素可能是ALS的重要病因因素,但需进一步研究。

核心结论

  • 在三个欧洲国家的女性中,外源性雌激素和孕激素与ALS风险降低相关。
  • 激素替代治疗的关联仅在荷兰显著,研究间存在异质性。
  • 结果与既往研究不同,可能与各国对妊娠、避孕和激素替代治疗的态度差异有关。

研究设计与样本

  • 在爱尔兰、意大利和荷兰进行为期4年的病例对照研究。
  • 纳入653例女性ALS患者和1217例匹配对照。
  • 使用经验证的问卷记录生殖史、母乳喂养、避孕药使用、激素替代治疗和妇科手术史。
  • 采用逻辑回归模型,调整年龄、教育、研究中心、吸烟、饮酒和体力活动。

主要发现

  • 口服避孕药使用在对照组中更常见(OR 0.65,95%CI 0.51-0.84),且呈剂量反应效应。
  • 激素替代治疗仅在荷兰与ALS风险降低相关(OR 0.57,95%CI 0.37-0.85)。
  • 敏感性分析结果稳健,但研究地点间存在一定异质性。

临床怎么用

  • 临床评估女性ALS风险时,可关注口服避孕药和激素替代治疗等激素暴露史。
  • 激素替代治疗的获益可能因国家或人群而异,需结合本地数据解读。

局限性

  • 研究地点间存在异质性,可能影响结果的普遍性。
  • 结果与既往研究不同,需进一步研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To investigate the role of hormonal risk factors for amyotrophic lateral sclerosis (ALS) among women from 3 European countries. METHODS: ALS cases and matched controls were recruited over 4 years in Ireland, Italy, and the Netherlands. Hormonal exposures, including reproductive history, breastfeeding, contraceptive use, hormonal replacement therapy, and gynecologic surgical history, were recorded with a validated questionnaire. Logistic regression models adjusted for age, education, study site, smoking, alcohol, and physical activity were used to determine the association between female hormones and ALS risk. RESULTS: We included 653 patients and 1,217 controls. Oral contraceptive use was higher among controls (odds ratio [OR] 0.65, 95% confidence interval [CI] 0.51-0.84), and a dose-response effect was apparent. Hormone replacement therapy (HRT) was associated with a reduced risk of ALS only in the Netherlands (OR = 0.57, 95% CI 0.37-0.85). These findings were robust to sensitivity analysis, but there was some heterogeneity across study sites. CONCLUSIONS: This large case-control study across 3 different countries has demonstrated an association between exogenous estrogens and progestogens and reduced odds of ALS in women. These results are at variance with previous findings, which may be partly explained by differential regulatory, social, and cultural attitudes toward pregnancy, birth control, and HRT across the countries included. Our results indicate that hormonal factors may be important etiologic factors in ALS; however, a full understanding requires further investigation.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Rooney JPK, Visser AE, D'Ovidio F, et al. A case-control study of hormonal exposures as etiologic factors for ALS in women: Euro-MOTOR. Neurology. 2017. PMID: 28835399. doi:10.1212/WNL.0000000000004390

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。